On May 12, 2023, Paratek Pharmaceuticals, Inc announced that it has filed a preliminary proxy statement soliciting proxies and urged the shareholders to vote for its board nominees: Minnie Baylor-Henry, Michael F. Bigham and Robert S. Radie at the Companyâs annual general meeting scheduled to be held on July 6, 2023.
1st Jan change | Capi. | |
---|---|---|
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |